業績紹介

ページタイトル画像

2015年-2017年

  • 2017年
  • 2016年
  • 2015年

2017年

  1. Haga Y, Kanda T, Yasui S, Nakamura M, Ooka Y, Takahashi K, Wu S, Nakamoto S, Arai M, Chiba T, Maruyama H, Yokosuka O, Takada N, Moriyama M, Imazeki F, Kato N. Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature.Oncotarget. 2017 Dec 29;9(4):5509-5513. doi:10.18632/oncotarget.23768. eCollection 2018 Jan 12.PMID:29435197

  2. Nakamoto S, Imazeki F, Kanda T, Wu S, Nakamura M, Yasui S, Tawada A, Mikata R, Chiba T, Arai M, Yokosuka O, Shirasawa H. Association of IFNL3 Genotype with Hepatic Steatosis in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin Combination Therapy. Int J Med Sci. 2017 Sep 4;14(11):1088-1093. doi: 10.7150/ijms.20171. eCollection 2017.PMID:29104462

  3. Nakao M, Nakayama N, Uchida Y, Tomiya T, Ido A, Sakaida I, Yokosuka O, Takikawa Y, Inoue K, Genda T, Shimizu M, Terai S, Tsubouchi H, Takikawa H, Mochida S. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2017 Oct 13. doi: 10.1007/s00535-017-1394-2. [Epub ahead of print] PMID:29030713.

  4. Ogasawara S, Chiba T, Ooka Y, Suzuki E, Maeda T, Yokoyama M, Wakamatsu T, Inoue M, Saito T, Kobayashi K, Kiyono S, Nakamura M, Nakamoto S, Yasui S, Tawada A, Arai M, Kanda T, Maruyama H, Yokosuka O, Kato N. Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment. Invest New Drugs. 2017 Sep 11. doi: 10.1007/s10637-017-0507-3. [Epub ahead of print]PMID:28891038

  5. Sogawa K, Kobayashi K, Kikkawa S, Takano S, Yoshitomi H, Takizawa H, Ohtsuka M, Shimizu H, Furuhata K, Miyazaki M, Yokosuka O, Nomura F. Development of a sandwich ELISA for the thrombin light chain identified by serum proteome analysis. Pract Lab Med. 2017 Apr 22;8:34-40. doi: 10.1016/j.plabm.2017.04.004. eCollection 2017 Aug.PMID:28856225

  6. Odaka T, Yamato S, Yokosuka O. Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial. Curr Ther Res Clin Exp. 2017 Apr 4;84:37-41. doi: 10.1016/j.curtheres.2017.03.007. eCollection 2017.PMID:28761578

  7. Kobayashi K, Maruyama H, Kiyono S, Yokosuka O, Ohtsuka M, Miyazaki M, Matsushima J, Kishimoto T, Nakatani Y. Histology-Based Assessment of Sonazoid-Enhanced Ultrasonography for the Diagnosis of Liver Metastasis.Ultrasound Med Biol. 2017 Oct;43(10):2151-2158. doi: 10.1016/j.ultrasmedbio.2017.06.014. Epub 2017 Jul 26.PMID:28755791

  8. Ogasawara S, Chiba T, Ooka Y, Kanogawa N, Motoyama T, Suzuki E, Tawada A, Nagai K, Nakagawa T, Sugawara T, Hanaoka H, Kanai F, Yokosuka O. A randomized placebo-controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization. Hepatology. 2017 Jul 26. doi: 10.1002/hep.29403. [Epub ahead of print] PMID:28746788

  9. Fujiwara K, Yasui S, Yokosuka O, Oda S, Kato N. Diagnostic utility of radiological heterogeneity in acute severe (fulminant) autoimmune hepatitis. J Hepatobiliary Pancreat Sci. 2017 Aug;24(8):485-491. doi: 10.1002/jhbp.487. Epub 2017 Jul 30.PMID:28660716

  10. Kanda T, Jiang X, Nakamura M, Haga Y, Sasaki R, Wu S, Nakamoto S, Imazeki F, Yokosuka O. Overexpression of the androgen receptor in human hepatoma cells and its effect on fatty acid metabolism. Oncol Lett. 2017 Jun;13(6):4481-4486. doi: 10.3892/ol.2017.5973. Epub 2017 Apr 3.PMID:28599448

  11. Jiang X, Kanda T, Haga Y, Sasaki R, Nakamura M, Wu S, Nakamoto S, Shirasawa H, Okamoto H, Yokosuka O. Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication. Exp Ther Med. 2017 Jun;13(6):3305-3308. doi: 10.3892/etm.2017.4407. Epub 2017 Apr 28.PMID:28587404

  12. Kanda T, Nakamura M, Yasui S, Haga Y, Tawada A, Suzuki E, Ooka Y, Takahashi K, Sasaki R, Wu S, Nakamoto S, Arai M, Imazeki F, Yokosuka O. Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin.Biology (Basel). 2017 May 9;6(2). pii: E30. doi: 10.3390/biology6020030.PMID:28486403

  13. Nakamura M, Kanda T, Jiang X, Haga Y, Takahashi K, Wu S, Yasui S, Nakamoto S, Yokosuka O. Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis.PLoS One. 2017 May 5;12(5):e0177302. doi: 10.1371/journal.pone.0177302. eCollection 2017.PMID:28475652

  14. Kanda T, Takahashi K, Nakamura M, Nakamoto S, Wu S, Haga Y, Sasaki R, Jiang X, Yokosuka O. Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma.Cancers (Basel). 2017 May 5;9(5). pii: E43. doi: 10.3390/cancers9050043.PMID:28475115

  15. Kanda T, Yasui S, Nakamura M, Suzuki E, Arai M, Ooka Y, Ogasawara S, Chiba T, Saito T, Haga Y, Takahashi K, Sasaki R, Wu S, Nakamoto S, Tawada A, Maruyama H, Imazeki F, Kato N, Yokosuka O. Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors.Int J Mol Sci. 2017 Apr 25;18(5). pii: E906. doi: 10.3390/ijms18050906.PMID:28441362

  16. Yokoyama M, Chiba T, Zen Y, Oshima M, Kusakabe Y, Noguchi Y, Yuki K, Koide S, Tara S, Saraya A, Aoyama K, Mimura N, Miyagi S, Inoue M, Wakamatsu T, Saito T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Otsuka M, Miyazaki M, Yokosuka O, Iwama A. Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma. Oncotarget. 2017 Mar 28;8(13):21315-21326. doi: 10.18632/oncotarget.15528. PMID:28423509

  17. Maiwall R, Sarin SK, Kumar S, Jain P, Kumar G, Bhadoria AS, Moreau R, Kedarisetty CK, Abbas Z, Amarapurkar D, Bhardwaj A, Bihari C, Butt AS, Chan A, Chawla YK, Chowdhury A, Dhiman R, Dokmeci AK, Ghazinyan H, Hamid SS, Kim DJ, Komolmit P, Lau GK, Lee GH, Lesmana LA, Jamwal K, Mamun-Al-Mahtab, Mathur RP, Nayak SL, Ning Q, Pamecha V, Alcantara-Payawal D, Rastogi A, Rahman S, Rela M, Saraswat VA, Shah S, Shiha G, Sharma BC, Sharma MK, Sharma K, Tan SS, Chandel SS, Vashishtha C, Wani ZA, Yuen MF, Yokosuka O, Duseja A, Jafri W, Devarbhavi H, Eapen CE, Goel A, Sood A, Ji J, Duan Z, Chen Y; of the APASL ACLF Research Consortium (AARC) working party. Development of predisposition, injury, response, organ failure model for predictingacute kidney injury in acute on chronic liver failure. Liver Int. 2017 Oct;37(10):1497-1507. doi: 10.1111/liv.13443. Epub 2017 Aug 2. PMID:28393476

  18. Choudhury A, Kumar M, Sharma BC, Maiwall R, Pamecha V, Moreau R, Chawla YK, Duseja A, Mahtab M, Rahman S, Hamid SS, Butt AS, Jafri W, Tan SS, Devarbhavi H, Amarapurkar D, Ning Q, Eapen CE, Goel A, Kim DJ, Ghazinyan H, Shiha G, Lee GH, Abbas Z, Payawal DA, Dokmeci AK, Yuen MF, Lesmana LA, Sood A, Chan A, Lau GK, Jia JD, Duan Z, Yu C, Yokosuka O, Jain P, Bhadoria AS, Kumar G, Sarin SK; APASL ACLF working party. Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective study. J Gastroenterol Hepatol. 2017 Dec;32(12):1989-1997. doi: 10.1111/jgh.13799.PMID:28374414

  19. Maruyama H, Kobayashi K, Kiyono S, Yokosuka O. Interrelationship between insulin resistance and portal haemodynamic abnormality in cirrhosis. Int J Med Sci. 2017 Feb 23;14(3):240-245. doi: 10.7150/ijms.17738. eCollection 2017.PMID:28367084

  20. Haga Y, Kanda T, Nakamoto S, Nakamura M, Sasaki R, Wu S, Yokosuka O. Interferon induces interleukin 8 and bone marrow stromal cell antigen 2 expression, inhibiting the production of hepatitis B virus surface antigen from human hepatocytes. Biochem Biophys Res Commun. 2017 May 6;486(3):858-863. doi: 10.1016/j.bbrc.2017.03.150. Epub 2017 Mar 28.PMID:28363866

  21. Sakai Y, Tsuyuguchi T, Mikata R, Sugiyama H, Yasui S, Miyazaki M, Yokosuka O. Utility of endoscopic retrograde cholangiopancreatography on biliopancreatic diseases in patients with Billroth II-reconstructed stomach. World J Gastrointest Endosc. 2017 Mar 16;9(3):127-132. doi: 10.4253/wjge.v9.i3.127.PMID:28360974

  22. Haga Y, Kanda T, Nakamura M, Nakamoto S, Sasaki R, Takahashi K, Wu S, Yokosuka O. Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines.PLoS One. 2017 Mar 21;12(3):e0174153. doi: 10.1371/journal.pone.0174153. eCollection 2017.PMID:28323861

  23. Maruyama H, Yokosuka O. Ultrasonography for Noninvasive Assessment of Portal Hypertension. Gut Liver. 2017 Jul 15;11(4):464-473. doi: 10.5009/gnl16078. Review. PMID:28267700

  24. Sakai Y, Tsuyuguchi T, Hirata N, Nakaji S, Shimura K, Nishikawa T, Fujimoto T, Hamano T, Nishino T, Yokosuka O. Clinical utility of 0.025-inch guidewire VisiGlide2TM in the endoscopic retrograde cholangiopancreatography-related procedures. World J Gastrointest Endosc. 2017 Feb 16;9(2):77-84. doi: 10.4253/wjge.v9.i2.77. PMID:28250900

  25. Sakurai T, Katsuno T, Saito K, Yoshihama S, Nakagawa T, Koseki H, Taida T, Ishigami H, Okimoto KI, Maruoka D, Matsumura T, Arai M, Yokosuka O. Mesenteric findings of CT enterography are well correlated with the endoscopic severity of Crohn's disease. Eur J Radiol. 2017 Apr;89:242-248. doi: 10.1016/j.ejrad.2016.10.022. Epub 2016 Nov 27.PMID:28188060

  26. Win NN, Nakamoto S, Kanda T, Takahashi H, Takahashi-Nakaguchi A, Yasui S, Nakamura M, Wu S, Imazeki F, Mikami S, Yokosuka O, Gonoi T, Shirasawa H. Discrepancy between Hepatitis C Virus Genotypes and NS4-Based Serotypes: Association with Their Subgenomic Sequences. Int J Mol Sci. 2017 Jan 17;18(1). pii: E172. doi: 10.3390/ijms18010172. PMID:28106726

  27. Wakamatsu T, Ogasawara S, Chiba T, Yokoyama M, Inoue M, Kanogawa N, Saito T, Suzuki E, Ooka Y, Tawada A, Yokosuka O. Impact of Radiofrequency Ablation-Induced Glisson's Capsule-Associated Complications in Patients with Hepatocellular Carcinoma. PLoS One. 2017 Jan 18;12(1):e0170153. doi: 10.1371/journal.pone.0170153. eCollection 2017.PMID:28099460

  28. Kawashima M, Hitomi Y, Aiba Y, Nishida N, Kojima K, Kawai Y, Nakamura H, Tanaka A, Zeniya M, Hashimoto E, Ohira H, Yamamoto K, Abe M, Nakao K, Yamagiwa S, Kaneko S, Honda M, Umemura T, Ichida T, Seike M, Sakisaka S, Harada M, Yokosuka O, Ueno Y, Senju M, Kanda T, Shibata H, Himoto T, Murata K, Miyake Y, Ebinuma H, Taniai M, Joshita S, Nikami T, Ota H, Kouno H, Kouno H, Nakamuta M, Fukushima N, Kohjima M, Komatsu T, Komeda T, Ohara Y, Muro T, Yamashita T, Yoshizawa K, Nakamura Y, Shimada M, Hirashima N, Sugi K, Ario K, Takesaki E, Naganuma A, Mano H, Yamashita H, Matsushita K, Yamauchi K, Makita F, Nishimura H, Furuta K, Takahashi N, Kikuchi M, Masaki N, Tanaka T, Tamura S, Mori A, Yagi S, Shirabe K, Komori A, Migita K, Ito M, Nagaoka S, Abiru S, Yatsuhashi H, Yasunami M, Shimoda S, Harada K, Egawa H, Maehara Y, Uemoto S, Kokudo N, Takikawa H, Ishibashi H, Chayama K, Mizokami M, Nagasaki M, Tokunaga K, Nakamura M. Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population. Hum Mol Genet. 2017 Feb 1;26(3):650-659. doi: 10.1093/hmg/ddw406. PMID:28062665

  29. Nwe Win N, Kanda T, Nakamura M, Nakamoto S, Okamoto H, Yokosuka O, Shirasawa H. Free fatty acids or high-concentration glucose enhances hepatitis A virus replication in association with a reduction in glucose-regulated protein 78 expression. Biochem Biophys Res Commun. 2017 Jan 29;483(1):694-699. doi: 10.1016/j.bbrc.2016.12.080. Epub 2016 Dec 13.PMID:27986562

  30. Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, Pracht M, Yokosuka O, Rosmorduc O, Breder V, Gerolami R, Masi G, Ross PJ, Song T, Bronowicki JP, Ollivier-Hourmand I, Kudo M, Cheng AL, Llovet JM, Finn RS, LeBerre MA, Baumhauer A, Meinhardt G, Han G; RESORCE Investigators. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017 Jan 7;389(10064):56-66. doi: 10.1016/S0140-6736(16)32453-9. Epub 2016 Dec 6. Erratum in: Lancet. 2017 Jan 7;389(10064):36. PMID:27932229

  31. Nakagawa S, Nakamura Y, Yasui S, Yokosuka O, Matsue H. A case of leucocytoclastic vasculitis as a complication of IgG4-related skin disease. Clin Exp Dermatol. 2017 Mar;42(2):235-236. doi: 10.1111/ced.13020. Epub 2016 Nov 29. No abstract available. PMID:27896847

  32. Miura Y, Kanda T, Yasui S, Takahashi K, Haga Y, Sasaki R, Nakamura M, Wu S, Nakamoto S, Arai M, Nishizawa T, Okamoto H, Yokosuka O. Hepatitis A virus genotype IA-infected patient with marked elevation of aspartate aminotransferase levels. Clin J Gastroenterol. 2017 Feb;10(1):52-56. doi: 10.1007/s12328-016-0700-5. Epub 2016 Nov 15.PMID:27848147

  33. Inoue M, Ogasawara S, Chiba T, Ooka Y, Wakamatsu T, Kobayashi K, Suzuki E, Tawada A, Yokosuka O. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 2017 Apr;32(4):908-915. doi: 10.1111/jgh.13622. PMID:27787908

  34. Kudo M, Hatano E, Ohkawa S, Fujii H, Masumoto A, Furuse J, Wada Y, Ishii H, Obi S, Kaneko S, Kawazoe S, Yokosuka O, Ikeda M, Ukai K, Morita S, Tsuji A, Kudo T, Shimada M, Osaki Y, Tateishi R, Sugiyama G, Abada PB, Yang L, Okusaka T, Zhu AX. Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial. J Gastroenterol. 2017 Apr;52(4):494-503. doi: 10.1007/s00535-016-1247-4. Epub 2016 Aug 22.PMID:27549242

  35. Maruoka D, Arai M, Kasamatsu S, Ishigami H, Taida T, Okimoto K, Saito K, Matsumura T, Nakagawa T, Katsuno T, Yokosuka O. Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: A propensity score-matching analysis. Dig Endosc. 2017 Jan;29(1):57-64. doi: 10.1111/den.12705. Epub 2016 Sep 5. PMID:27492962

  36. Ishigami H, Arai M, Matsumura T, Maruoka D, Minemura S, Okimoto K, Kasamatsu S,Saito K, Nakagawa T, Katsuno T, Yokosuka O. Heparin-bridging therapy is associated with a high risk of post-polypectomy bleeding regardless of polyp size. Dig Endosc. 2017 Jan;29(1):65-72. doi: 10.1111/den.12692. Epub 2016 Jul 28. PMID:27368065

  37. Taida T, Arai M, Kanda T, Hige S, Ueno Y, Imazeki F, Izumi N, Tanaka E, Shinkai N, Yoshioka K, Nakamoto Y, Nishiguchi S, Tsuge M, Abe M, Sata M, Yatsuhashi H, Ido A, Kita K, Azemoto R, Kitsukawa Y, Goto N, Yokosuka O. The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study. J Gastroenterol. 2017 Jan;52(1):113-122. doi: 10.1007/s00535-016-1229-6. Epub 2016 Jun 15.PMID:27306374

  38. Rizq O, Mimura N, Oshima M, Saraya A, Koide S, Kato Y, Aoyama K, Nakajima-Takagi Y, Wang C, Chiba T, Ma A, Jin J, Iseki T, Nakaseko C, Iwama A.  Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition. Clin Cancer Res. 2017 Aug 15;23(16):4817-4830. doi: 10.1158/1078-0432.CCR-16-2735. Epub 2017 May 10. PMID: 28490465

  39. Kaneta Y, Arai MA, Ishikawa N, Toume K, Koyano T, Kowithayakorn T, Chiba T, Iwama A, Ishibashi M. Identification of BMI1 Promoter Inhibitors from Beaumontia murtonii and Eugenia operculata. J Nat Prod. 2017 Jun 23;80(6):1853-1859. doi: 10.1021/acs.jnatprod.7b00138. Epub 2017 Jun 9. PMID: 28598616

  40. Akizue N, Suzuki E, Yokoyama M, Inoue M, Wakamatsu T, Saito T, Kusakabe Y, Ogasawara S, Ooka Y, Tawada A, Maru Y, Matsue H, Chiba T. Henoch-Schönlein Purpura Complicated by Hepatocellular Carcinoma. Intern Med. 2017 Nov 15;56(22):3041-3045. doi: 10.2169/internalmedicine.8885-17. Epub 2017 Sep 25. PMID: 28943572

2016年

  1. Haga Y, Kanda T, Sasaki R, Nakamura M, Takahashi K, Wu S, Yasui S, Arai M, NakamotoS,Yokosuka O. Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Could Not Always Predict Early Cirrhosis in Non-Viral Liver Diseases. Diseases. 2016 Dec 14;4(4). pii: E38. doi: 10.3390/diseases4040038. PMID:28933417

  2. Takahashi K, Kanda T, Yasui S, Haga Y, Kumagai J, Sasaki R, Wu S, Nakamoto S, NakamuraM, Arai M, Yokosuka O.Drug-Induced Liver Injury Associated with Complementary and Alternative Medicines.Case Rep Gastroenterol. 2016 Nov 25;10(3):706-713. doi: 10.1159/000452209. eCollection 2016 Sep-Dec. PMID: 28100990

  3. Tanaka A, Ma X, Yokosuka O, Weltman M, You H, Amarapurkar DN, Kim YJ, Abbas Z, Payawal DA, Chang ML, Efe C, Ozaslan E, Abe M, Mitchell-Thain R, Zeniya M, Han KH, Vierling JM, Takikawa H. Autoimmune liver diseases in the Asia-Pacific region: Proceedings of APASL symposium on AIH and PBC 2016.Hepatol Int. 2016 Nov;10(6):909-915. Epub 2016 Sep 20. Review.PMID: 27649967

  4. Nakaji S, Hirata N, Mikata R, Kobayashi M, Shiratori T, Ogasawara S, Ooka Y, Tsuyuguchi T, Yamaguchi T, Yokosuka O. Clinical outcomes of endoscopic ultrasound-guided ethanol injection for hepatocellular carcinoma in the caudate lobe.Endosc Int Open. 2016 Oct;4(10):E1111-E1115. Epub 2016 Sep 30.PMID: 27747288

  5. Sasaki R, Kanda T, Ohtsuka M, Yasui S, Haga Y, Nakamura M, Yokoyama M, Wu S, Nakamoto S, Arai M, Maruyama H, Miyazaki M, Yokosuka O. Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin.Case Rep Gastroenterol. 2016 Jul 20;10(2):366-372. eCollection 2016 May-Aug.PMID: 27721720

  6. Sogawa K, Takano S, Iida F, Satoh M, Tsuchida S, Kawashima Y, Yoshitomi H, Sanda A, Kodera Y, Takizawa H, Mikata R, Ohtsuka M, Shimizu H, Miyazaki M, Yokosuka O, Nomura F. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags. Br J Cancer. 2016 Oct 11;115(8):949-956. doi: 10.1038/bjc.2016.295. Epub 2016 Sep 22. PMID:27657339

  7. Ogasawara S, Chiba T, Motoyama T, Kanogawa N, Saito T, Shinozaki Y, Suzuki E, Ooka Y, Tawada A, Kato H, Okabe S, Kanai F, Yoshikawa M, Yokosuka O. Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma. PLoS One. 2016 Sep 20;11(9):e0163119. doi: 10.1371/journal.pone.0163119. eCollection 2016. PMID:27649084

  8. Saito K, Nakagawa T, Koseki H, Taida T, Sakurai T, Yoshihama S, Saito M, Maruoka D, Matsumura T, Watabe H, Arai M, Katsuno T, Yokosuka O. Retention of the cellophane wall of a patency capsule by intestinal stenosis: a report of three cases. Clin J Gastroenterol. 2016 Dec;9(6):365-368. Epub 2016 Sep 17. PMID:27640052

  9. Yasui S, Fujiwara K, Haga Y, Nakamura M, Mikata R, Arai M, Kanda T, Oda S, Yokosuka O. Infectious complications, steroid use and timing for emergency liver transplantation in acute liver failure: analysis in a Japanese center. J Hepatobiliary Pancreat Sci. 2016 Dec;23(12):756-762. doi: 10.1002/jhbp.399. Epub 2016 Oct 6. PMID:27629813

  10. Sakai Y, Tsuyuguchi T, Sugiyama H, Hayashi M, Senoo J, Sasaki R, Kusakabe Y,Nakamura M, Yasui S, Mikata R, Miyazaki M, Yokosuka O. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by pancreatic duct stenting using a loop-tipped guidewire. World J Clin Cases. 2016 Aug 16;4(8):213-8. doi: 10.12998/wjcc.v4.i8.213. PMID:27574608

  11. Ogasawara S, Chiba T, Ooka Y, Suzuki E, Inoue M, Wakamatsu T, Tawada A, Yokosuka O. Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular Carcinoma. PLoS One. 2016 Aug 18;11(8):e0161303. doi: 10.1371/journal.pone.0161303. eCollection 2016. PMID:27537374

  12. Kiyono S, Maruyama H, Kondo T, Sekimoto T, Shimada T, Takahashi M, Yokosuka O. Erratum to: Hemodynamic effect of the left gastric artery on esophageal varices in patients with cirrhosis. J Gastroenterol. 2016 Dec;51(12):1175. No abstract available. PMID:27535062

  13. Win NN, Kanda T, Nakamoto S, Yokosuka O, Shirasawa H. Hepatitis C virus genotypes in Myanmar. World J Gastroenterol. 2016 Jul 21;22(27):6095-9. doi: 10.3748/wjg.v22.i27.6095. PMID:27468202

  14. Sasaki R, Kanda T, Yasui S, Haga Y, Nakamura M, Yamato M, Wu S, Nakamoto S, Arai M, Mikami S, Miyauchi H, Matsubara H, Yokosuka O. Successful Eradication of Hepatitis C Virus by Interferon-Free Regimens in Two Patients with Advanced Liver Fibrosis following Kidney Transplantation. Case Rep Gastroenterol. 2016 May 27;10(2):248-56. doi: 10.1159/000445374. eCollection 2016 May-Aug. PMID:27462193

  15. Maruyama H, Kobayashi K, Kiyono S, Sekimoto T, Kanda T, Yokosuka O. Two-dimensional shear wave elastography with propagation-based reliability assessment for grading hepatic fibrosis and portal hypertension. J Hepatobiliary Pancreat Sci. 2016 Sep;23(9):595-602. doi: 10.1002/jhbp.379. Epub 2016 Aug 24. PMID:27440720

  16. Haga Y, Yasui S, Kanda T, Hattori N, Wakamatsu T, Nakamura M, Sasaki R, Wu S, Nakamoto S, Arai M, Maruyama H, Ohtsuka M, Oda S, Miyazaki M, Yokosuka O. Successful Management of Acute Liver Failure Patients Waiting for Liver Transplantation by On-Line Hemodiafiltration with an Arteriovenous Fistula. Case Rep Gastroenterol. 2016 May 19;10(1):139-45. doi: 10.1159/000445186. eCollection 2016 Jan-Apr. PMID:27403116

  17. Ohta Y, Kanda T, Katsuno T, Yasui S, Haga Y, Sasaki R, Nakamura M, Wu S, Nakamoto S, Arai M, Yokosuka O. Successful sofosbuvir treatment with ribavirin dose reduction for chronic hepatitis C virus genotype 2 infection in a patient with ulcerative colitis: a case report. BMC Gastroenterol. 2016 Jul 11;16(1):66. doi: 10.1186/s12876-016-0480-x. PMID:27401874

  18. Morimoto M, Lee EY, Zhang X, Inaba Y, Inoue H, Ogawa M, Shirasawa T, Yokosuka O, Miki T. Eicosapentaenoic acid ameliorates hyperglycemia in high-fat diet-sensitive diabetes mice in conjunction with restoration of hypoadiponectinemia. Nutr Diabetes. 2016 Jun 27;6:e213. doi: 10.1038/nutd.2016.21. PMID:27348201

  19. Wu S, Kanda T, Nakamoto S, Jiang X, Nakamura M, Sasaki R, Haga Y, Shirasawa H, Yokosuka O. Cooperative effects of hepatitis B virus and TNF may play important roles in the activation of metabolic pathways through the activation of NF-κB. Int J Mol Med. 2016 Aug;38(2):475-81. doi: 10.3892/ijmm.2016.2643. Epub 2016 Jun 16. PMID:27315566

  20. Kanda T, Yasui S, Nakamura M, Suzuki E, Arai M, Haga Y, Sasaki R, Wu S, Nakamoto S, Imazeki F, Yokosuka O. Daclatasvir plus Asunaprevir Treatment for Real-World HCV Genotype 1-Infected Patients in Japan. Int J Med Sci. 2016 May 12;13(6):418-23. doi: 10.7150/ijms.15519. eCollection 2016. PMID:27279790

  21. Sakai Y, Tsuyuguchi T, Sugiyama H, Hayashi M, Senoo J, Kusakabe Y, Yasui S, Mikata R, Yokosuka O. Comparison of endoscopic papillary balloon dilatation and endoscopic sphincterotomy for bile duct stones. World J Gastrointest Endosc. 2016 May 25;8(10):395-401. doi: 10.4253/wjge.v8.i10.395. Review. PMID:27247706

  22. Omata M, Kanda T, Wei L, Yu ML, Chuang WL, Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Al-Mahtab M, McCaughan GW, Wasim J, Crawford DH, Kao JH, Yokosuka O, Lau GK, Sarin SK. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing. Hepatol Int. 2016 Sep;10(5):681-701. doi: 10.1007/s12072-016-9736-3. Epub 2016 May 26. Review. PMID:27229718

  23. Kumagai J, Kanda T, Yasui S, Haga Y, Sasaki R, Nakamura M, Wu S, Nakamoto S, Arai M, Iino Y, Yokosuka O. Autoimmune hepatitis following drug-induced liver injury in an elderly patient. Clin J Gastroenterol. 2016 Jun;9(3):156-9. doi: 10.1007/s12328-016-0648-5. Epub 2016 May 12. PMID:27170297

  24. Kiyono S, Maruyama H, Kobayashi K, Kondo T, Sekimoto T, Shimada T, Yokosuka O, Yamaguchi T. Non-Invasive Diagnosis of Portal Hypertensive Gastropathy: Quantitative Analysis of Microbubble-Induced Stomach Wall Enhancement. Ultrasound Med Biol. 2016 Aug;42(8):1792-9. doi: 10.1016/j.ultrasmedbio.2016.03.011. Epub 2016 May 7. PMID:27166020

  25. Omata M, Kanda T, Wei L, Yu ML, Chuang WL, Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Mamun-Al-Mahtab, McCaughan GW, Wasim J, Crawford DH, Kao JH, Yokosuka O, Lau GK, Sarin SK. APASL consensus statements and recommendation on treatment of hepatitis C. Hepatol Int. 2016 Sep;10(5):702-26. doi: 10.1007/s12072-016-9717-6. Epub 2016 Apr 29. Review. PMID:27130427

  26. Nishida N, Ohashi J, Khor SS, Sugiyama M, Tsuchiura T, Sawai H, Hino K, Honda M, Kaneko S, Yatsuhashi H, Yokosuka O, Koike K, Kurosaki M, Izumi N, Korenaga M, Kang JH, Tanaka E, Taketomi A, Eguchi Y, Sakamoto N, Yamamoto K, Tamori A, Sakaida I, Hige S, Itoh Y, Mochida S, Mita E, Takikawa Y, Ide T, Hiasa Y, Kojima H, Yamamoto K, Nakamura M, Saji H, Sasazuki T, Kanto T, Tokunaga K, Mizokami M. Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis. Sci Rep. 2016 Apr 19;6:24767. doi: 10.1038/srep24767. PMID:27091392

  27. Kanda T, Nakamoto S, Sasaki R, Nakamura M, Yasui S, Haga Y, Ogasawara S, Tawada A, Arai M, Mikami S, Imazeki F, Yokosuka O. Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin. Int J Med Sci. 2016 Apr 10;13(4):310-5. doi: 10.7150/ijms.14953. eCollection 2016. PMID:27076789

  28. Sasaki R, Sakai Y, Tsuyuguchi T, Nishikawa T, Fujimoto T, Mikami S, Sugiyama H, Yokosuka O. Endoscopic management of unresectable malignant gastroduodenal obstruction with a nitinol uncovered metal stent: A prospective Japanese multicenter study. World J Gastroenterol. 2016 Apr 14;22(14):3837-44. doi: 10.3748/wjg.v22.i14.3837. PMID:27076769

  29. Arai M, Okimoto K, Ishigami H, Taida T, Oyamada A, Minemura S, Saito K, Tsuboi M, Maruoka D, Matsumura T, Nakagawa T, Katsuno T, Mitsuhashi K, Nakagawa Y, Yamaguchi K, Yokosuka O. A randomized controlled trial comparing water exchange and air insufflation during colonoscopy without sedation. Int J Colorectal Dis. 2016 Jun;31(6):1217-23. doi: 10.1007/s00384-016-2580-z. Epub 2016 Apr 8. PMID:27059039

  30. Tawada A, Kanda T, Imazeki F, Yokosuka O. Prevention of hepatitis B virus-associated liver diseases by antiviral therapy. Hepatol Int. 2016 Jul;10(4):574-93. doi: 10.1007/s12072-016-9720-y. Epub 2016 Mar 29. Review. PMID:27026375

  31. Maruyama H, Kiyono S, Kondo T, Sekimoto T, Yokosuka O. Palmitate-induced Regulation of PPARγ via PGC1α: a Mechanism for Lipid Accumulation in the Liver in Nonalcoholic Fatty Liver Disease. Int J Med Sci. 2016 Feb 11;13(3):169-78. doi: 10.7150/ijms.13581. eCollection 2016. PMID:26941577

  32. Tawada A, Chiba T, Saito T, Ogasawara S, Suzuki E, Ooka Y, Arai M, Kanda T, Shinozaki M, Goto N, Nagashima K, Yokosuka O. Utility of Prediction Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Treated with Nucleos(t)ide Analogues. Oncology. 2016;90(4):199-208. doi: 10.1159/000444392. Epub 2016 Mar 3. PMID:26934505

  33. Kobayashi K, Maruyama H, Kiyono S, Sekimoto T, Kondo T, Shimada T, Takahashi M, Okugawa H, Yokosuka O. Portal response related to shunt occlusion by balloon-occluded retrograde transvenous obliteration may determine the prognosis of cirrhosis. Hepatol Res. 2016 Dec;46(13):1321-1329. doi: 10.1111/hepr.12690. Epub 2016 May 10. PMID:26931092

  34. Ohyama H, Mikata R, Ishihara T, Tsuyuguchi T, Sakai Y, Sugiyama H, Yasui S, Yokosuka O. Reply to Xie S, Mai G. Comments on Comments on "Efficacy of Stone Density on Noncontrast Computed Tomography in Predicting the Outcome of Extracorporeal Shock Wave Lithotripsy for Patients With Pancreatic Stones" by Ohyama et al. Pancreas. 2016 Mar;45(3):e5-6. doi: 10.1097/MPA.0000000000000534. No abstract available. PMID:26863378

  35. Nakamura M, Kanda T, Haga Y, Sasaki R, Wu S, Nakamoto S, Yasui S, Arai M, Imazeki F, Yokosuka O. Sofosbuvir treatment and hepatitis C virus infection. World J Hepatol. 2016 Jan 28;8(3):183-90. doi: 10.4254/wjh.v8.i3.183. Review. PMID:26839641

  36. Fujiwara K, Yasui S, Yonemitsu Y, Arai M, Kanda T, Fukuda Y, Nakano M, Oda S, Yokosuka O. Analysis of infectious complications and timing for emergency liver transplantation in autoimmune acute liver failure. J Hepatobiliary Pancreat Sci. 2016 Apr;23(4):212-9. doi: 10.1002/jhbp.326. Epub 2016 Feb 21. PMID:26808231

  37. Kiyono S, Maruyama H, Kondo T, Sekimoto T, Shimada T, Takahashi M, Yokosuka O. Hemodynamic effect of the left gastric artery on esophageal varices in patients with cirrhosis. J Gastroenterol. 2016 Sep;51(9):900-9. doi: 10.1007/s00535-015-1157-x. Epub 2016 Jan 18. Erratum in: J Gastroenterol. 2016 Dec;51(12 ):1175. PMID:26781661

  38. Fujiwara K, Fukuda Y, Seza K, Saito M, Yasui S, Nakano M, Yokosuka O. High level of persistent liver injury is one of clinical characteristics in treatment-naïve acute onset autoimmune hepatitis: experience in a community hospital. J Hepatobiliary Pancreat Sci. 2016 Mar;23(3):174-80. doi: 10.1002/jhbp.319. Epub 2016 Feb 17. PMID:26751046

  39. Fujiwara K, Fukuda Y, Seza K, Saito M, Yasui S, Nakano M, Yokosuka O. High level of persistent liver injury is one of clinical characteristics in treatment-naïve acute onset autoimmune hepatitis: experience in a community hospital. J Hepatobiliary Pancreat Sci. 2016 Mar;23(3):174-80. doi: 10.1002/jhbp.319. Epub 2016 Feb 17. PMID:26751046

  40. Sasaki R, Kanda T, Nakamura M, Nakamoto S, Haga Y, Wu S, Shirasawa H, Yokosuka O. Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells. PLoS One. 2016 Jan 5;11(1):e0146314. doi: 10.1371/journal.pone.0146314. eCollection 2016. PMID:26731332

  41. Maruyama H, Shiha G, Yokosuka O, Kumar A, Sharma BC, Ibrahim A, Saraswat V, Lesmana CR, Omata M. Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonography.Hepatol Int. 2016 Mar;10(2):267-76. doi: 10.1007/s12072-015-9670-9. Epub 2015 Dec 22. Review. PMID:26696585

  42. Maruyama H, Sekimoto T, Yokosuka O. Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience. J Gastroenterol. 2016 May;51(5):421-33. doi: 10.1007/s00535-015-1151-3. Epub 2015 Dec 22. Review. PMID:26694825

  43. Mochida S, Nakayama N, Ido A, Takikawa Y, Yokosuka O, Sakaida I, Moriwaki H, Genda T, Takikawa H. Revised criteria for classification of the etiologies of acute liver failure and late-onset hepatic failure in Japan: A report by the Intractable Hepato-biliary Diseases Study Group of Japan in 2015. Hepatol Res. 2016 Mar;46(5):369-71. doi: 10.1111/hepr.12626. Epub 2016 Jan 19. PMID:26615003

  44. Kondo T, Maruyama H, Kiyono S, Sekimoto T, Shimada T, Takahashi M, Okugawa H, Yokosuka O, Kawahira H, Yamaguchi T. Eradication of esophageal varices by sclerotherapy combined with argon plasma coagulation: Effect of portal hemodynamics and longitudinal clinical course. Dig Endosc. 2016 Mar;28(2):152-61. doi: 10.1111/den.12562. Epub 2015 Nov 26. PMID:26505617

  45. Matsumura T, Arai M, Ishigami H, Okimoto K, Saito K, Minemura S, Maruoka D, Nakagawa T, Katsuno T, Yokosuka O. A randomized controlled trial comparing a prepackaged low-residue diet with a restricted diet for colonoscopy preparation: the impact on the results of colonoscopy in adenoma detection. Colorectal Dis. 2016 Jan;18(1):O37-42. doi: 10.1111/codi.13167. PMID:26496937

  46. Kondo T, Maruyama H, Sekimoto T, Shimada T, Takahashi M, Okugawa H, Yokosuka O. Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis. Scand J Gastroenterol. 2016;51(2):236-44. doi: 10.3109/00365521.2015.1081275. Epub 2015 Sep 10. PMID:26357874

  47. Nishikawa T, Shimura K, Tsuyuguchi T, Kiyono S, Yokosuka O. Contrast-enhanced harmonic EUS of pancreatic schwannoma. Gastrointest Endosc. 2016 Feb;83(2):463-4. doi: 10.1016/j.gie.2015.08.041. Epub 2015 Sep 1. No abstract available. PMID:26341855

  48. Sekimoto T, Maruyama H, Kobayashi K, Kiyono S, Kondo T, Shimada T, Takahashi M, Yokosuka O. Well-tolerated portal hypertension and favorable prognosis in adult patients with extrahepatic portal vein obstruction in Japan. Hepatol Res. 2016 May;46(6):505-13. doi: 10.1111/hepr.12581. Epub 2015 Nov 5. PMID:26333179

  49. Chiba T, Iwama A, Yokosuka O. Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology. Hepatol Res. 2016 Jan;46(1):50-7. doi: 10.1111/hepr.12548. Epub 2015 Jul 27. Review. PMID:26123821

  50. Fujiwara K, Yokosuka O, Inoue K, Yasui S, Abe R, Oda S, Arata S, Takikawa Y, Ido A, Mochida S, Tsubouchi H, Takikawa H; Intractable Hepato-Biliary Disease Study Group of Japan. Distribution of core hospitals for patients with fulminant hepatitis and late onset hepatic failure in Japan. Hepatol Res. 2016 Jan;46(1):10-2. doi: 10.1111/hepr.12543. No abstract available. PMID:26096326

  51. Koide S, Oshima M, Takubo K, Yamazaki S, Nitta E, Saraya A, Aoyama K, Kato Y, Miyagi S, Nakajima-Takagi Y, Chiba T, Matsui H, Arai F, Suzuki Y, Kimura H, Nakauchi H, Suda T, Shinkai Y, Iwama A. Setdb1 maintains hematopoietic stem and progenitor cells by restricting the ectopic activation of nonhematopoietic genes. Blood. 2016 Aug 4;128(5):638-49. doi: 10.1182/blood-2016-01-694810. Epub 2016 Jun 14. PMID: 27301860

2015年

  1. Kanaeda T, Ueda M, Arai M, Ishimura M, Kajiyama T, Hashiguchi N, Nakano M, Kondo Y, Hiranuma Y, Oyamada A, Yokosuka O, Kobayashi Y. Evaluation of periesophageal nerve injury after pulmonary vein isolation using the (13)C-acetate breath test. J Arrhythm. 2015 Dec;31(6):364-70. doi: 10.1016/j.joa.2015.06.004. PubMed PMID: 26702316; PubMed Central PMCID: PMC4672080.
  2. Haga Y, Kanda T, Sasaki R, Nakamura M, Nakamoto S, Yokosuka O. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis. World J Gastroenterol. 2015 Dec 14;21(46):12989-95. doi: 10.3748/wjg.v21.i46.12989. Review. PubMed PMID: 26675364; PubMed Central PMCID: PMC4674717.
  3. Nakamura M, Kanda T, Sasaki R, Haga Y, Jiang X, Wu S, Nakamoto S, Yokosuka O. MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells. PLoS One. 2015 Dec 4;10(12):e0144295. doi: 10.1371/journal.pone.0144295. PubMed PMID: 26636761; PubMed Central PMCID: PMC4670168.
  4. Kanda T, Nakamoto S, Wu S, Nakamura M, Jiang X, Haga Y, Sasaki R, Yokosuka O. Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus. J Clin Transl Hepatol. 2015 Sep 28;3(3):205-10. doi: 10.14218/JCTH.2015.00016. Review. PubMed PMID: 26623267; PubMed Central PMCID: PMC4663202.
  5. Kanda T, Yasui S, Nakamura M, Arai M, Sasaki R, Haga Y, Wu S, Nakamoto S, Okamoto H, Yokosuka O. Recent Trend of Hepatitis E Virus Infection in Chiba Area, Japan: 3 of 5 Cases with Rheumatoid Arthritis. Case Rep Gastroenterol. 2015 Oct 17;9(3):317-26. doi: 10.1159/000441387. PubMed PMID: 26600768; PubMed Central PMCID: PMC4649734.
  6. Nakagawa T, Katsuno T, Noguchi Y, Mandai Y, Yoshihama S, Saito K, Maruoka D, Matsumura T, Arai M, Yokosuka O. Irsogladine Maleate Prevents Colitis in Interleukin-10 Gene-Deficient Mice by Reducing Interleukin-12 and -23 Production. Biol Pharm Bull. 2015;38(11):1681-8. doi: 10.1248/bpb.b15-00189. PubMed PMID: 26521820.
  7. Suzuki E, Chiba T, Ogasawara S, Saito T, Kanogawa N, Motoyama T, Ooka Y, Tawada A, Maruyama H, Ogawa M, Yokosuka O. Tolvaptan treatment for patients with decompensated cirrhosis and advanced hepatocellular carcinoma. Hepatol Res. 2015 Oct;45(10):E161-2. doi: 10.1111/hepr.12465. PubMed PMID: 26510648.
  8. Sakai Y, Tsuyuguchi T, Nishikawa T, Sugiyama H, Sasaki R, Sakamoto D, Watanabe Y, Nakamura M, Yasui S, Mikata R, Yokosuka O. New tapered metallic stent for unresectable malignant hilar bile duct obstruction. World J Clin Cases. 2015 Oct 16;3(10):887-93. doi: 10.12998/wjcc.v3.i10.887. PubMed PMID: 26488025; PubMed Central PMCID: PMC4607807.
  9. Maruoka D, Arai M, Ishigami H, Okimoto K, Matsumura T, Nakagawa T, Yokosuka O. Cold polypectomy for nonampullary duodenal adenoma. Endoscopy. 2015;47 Suppl 1 UCTN:E477-8. doi: 10.1055/s-0034-1392668. PubMed PMID: 26479293.
  10. Ogasawara S, Chiba T, Ooka Y, Suzuki E, Kanogawa N, Saito T, Motoyama T, Tawada A, Kanai F, Yokosuka O. Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma. Invest New Drugs. 2015 Dec;33(6):1257-62. doi: 10.1007/s10637-015-0292-9. PubMed PMID: 26462681.
  11. Nishida N, Ohashi J, Sugiyama M, Tsuchiura T, Yamamoto K, Hino K, Honda M, Kaneko S, Yatsuhashi H, Koike K, Yokosuka O, Tanaka E, Taketomi A, Kurosaki M, Izumi N, Sakamoto N, Eguchi Y, Sasazuki T, Tokunaga K, Mizokami M. Effects of HLA-DPB1 genotypes on chronic hepatitis B infection in Japanese individuals. Tissue Antigens. 2015 Dec;86(6):406-12. doi: 10.1111/tan.12684. PubMed PMID: 26449183.
  12. Fujiwara K, Yasui S, Yokosuka O. Corticosteroid and nucleoside analogue for hepatitis B virus-related acute liver failure. World J Gastroenterol. 2015 Sep 28;21(36):10485-6. doi: 10.3748/wjg.v21.i36.10485. PubMed PMID: 26420977; PubMed Central PMCID: PMC4579897.
  13. Kanda T, Sasaki R, Nakamoto S, Haga Y, Nakamura M, Shirasawa H, Okamoto H, Yokosuka O. The sirtuin inhibitor sirtinol inhibits hepatitis A virus (HAV) replication by inhibiting HAV internal ribosomal entry site activity. Biochem Biophys Res Commun. 2015 Oct 23;466(3):567-71. doi: 10.1016/j.bbrc.2015.09.083. PubMed PMID: 26388050.
  14. Kondo T, Maruyama H, Kiyono S, Sekimoto T, Shimada T, Takahashi M, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Chiba T, Kanai F, Yokosuka O. Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma. Ultrasound Med Biol. 2015 Dec;41(12):3079-87. doi: 10.1016/j.ultrasmedbio.2015.07.033. PubMed PMID: 26371403.
  15. Nakamoto S, Imazeki F, Arai M, Yasui S, Nakamura M, Haga Y, Sasaki R, Kanda T, Shirasawa H, Yokosuka O. Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy. Int J Mol Sci. 2015 Sep 7;16(9):21177-90. doi: 10.3390/ijms160921177. PubMed PMID: 26370958; PubMed Central PMCID: PMC4613248.
  16. Sugiyama H, Tsuyuguchi T, Sakai Y, Mikata R, Yasui S, Watanabe Y, Sakamoto D, Nakamura M, Sasaki R, Senoo J, Kusakabe Y, Hayashi M, Yokosuka O. Current status of preoperative drainage for distal biliary obstruction. World J Hepatol. 2015 Aug 28;7(18):2171-6. doi: 10.4254/wjh.v7.i18.2171. Review. PubMed PMID: 26328029; PubMed Central PMCID: PMC4550872.
  17. Fujiwara K, Yasui S, Yokosuka O. Appropriate diagnostic criteria for fulminant autoimmune hepatitis. Eur J Gastroenterol Hepatol. 2015 Oct;27(10):1230-1. doi: 10.1097/MEG.0000000000000441. PubMed PMID: 26327503.
  18. Kanda T, Nakamoto S, Yokosuka O. Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C? World J Virol. 2015 Aug 12;4(3):178-84. doi: 10.5501/wjv.v4.i3.178. PubMed PMID: 26279979; PubMed Central PMCID: PMC4534809.
  19. Kanda T, Nakamura M, Sasaki R, Yasui S, Nakamoto S, Haga Y, Jiang X, Wu S, Tawada A, Arai M, Imazeki F, Yokosuka O. Sustained Virological Response after 8-Week Treatment of Simeprevir with Peginterferon α-2a plus Ribavirin in a Japanese Female with Hepatitis C Virus Genotype 1b and IL28B Minor Genotype. Case Rep Gastroenterol. 2015 Jul 8;9(2):215-20. doi: 10.1159/000437138. PubMed PMID: 26269697; PubMed Central PMCID: PMC4520186.
  20. Kondo T, Maruyama H, Sekimoto T, Shimada T, Takahashi M, Yokosuka O. Reversed portal flow: Clinical influence on the long-term outcomes in cirrhosis. World J Gastroenterol. 2015 Aug 7;21(29):8894-902. doi: 10.3748/wjg.v21.i29.8894. PubMed PMID: 26269679; PubMed Central PMCID: PMC4528032.
  21. Suzuki E, Chiba T, Ooka Y, Ogasawara S, Tawada A, Motoyama T, Kanogawa N, Saito T, Yoshikawa M, Yokosuka O. Transcatheter arterial infusion for advanced hepatocellular carcinoma: Who are candidates? World J Gastroenterol. 2015 Aug 7;21(29):8888-93. doi: 10.3748/wjg.v21.i29.8888. PubMed PMID: 26269678; PubMed Central PMCID: PMC4528031.
  22. Chiba T, Suzuki E, Saito T, Ogasawara S, Ooka Y, Tawada A, Iwama A, Yokosuka O. Biological features and biomarkers in hepatocellular carcinoma. World J Hepatol. 2015 Aug 8;7(16):2020-8. doi: 10.4254/wjh.v7.i16.2020. Review. PubMed PMID: 26261691; PubMed Central PMCID: PMC4528275.
  23. Kanda T, Ogasawara S, Chiba T, Haga Y, Omata M, Yokosuka O. Current management of patients with hepatocellular carcinoma. World J Hepatol. 2015 Jul 28;7(15):1913-20. doi: 10.4254/wjh.v7.i15.1913. PubMed PMID: 26244066; PubMed Central PMCID: PMC4517151.
  24. Sasaki R, Kanda T, Wu S, Nakamoto S, Haga Y, Jiang X, Nakamura M, Shirasawa H, Yokosuka O. Association between hepatitis B virus and MHC class I polypeptide-related chain A in human hepatocytes derived from human-mouse chimeric mouse liver. Biochem Biophys Res Commun. 2015 Sep 4;464(4):1192-5. doi: 10.1016/j.bbrc.2015.07.102. PubMed PMID: 26212443.
  25. Maruyama H, Kondo T, Sekimoto T, Kiyono S, Shimada T, Takahashi M, Okugawa H, Yokosuka O. Hyponatremia: a significant factor in a poor prognosis for cirrhosis with Child A/B after variceal eradication. J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):771-8. doi: 10.1002/jhbp.282. PubMed PMID: 26202665.
  26. Jiang X, Kanda T, Wu S, Nakamoto S, Nakamura M, Sasaki R, Haga Y, Wakita T, Shirasawa H, Yokosuka O. Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-κB-Nuclear Translocation. PLoS One. 2015 Jul 2;10(7):e0131973. doi: 10.1371/journal.pone.0131973. Erratum in: PLoS One. 2015;10(7):e0134068. PubMed PMID: 26133378; PubMed Central PMCID: PMC4489642.
  27. Maruyama H, Kondo T, Sekimoto T, Yokosuka O. Differential Clinical Impact of Ascites in Cirrhosis and Idiopathic Portal Hypertension. Medicine (Baltimore). 2015 Jul;94(26):e1056. doi: 10.1097/MD.0000000000001056. PubMed PMID: 26131820; PubMed Central PMCID: PMC4504543.
  28. Saito T, Chiba T, Ogasawara S, Inoue M, Wakamatsu T, Motoyama T, Kanogawa N, Suzuki E, Ooka Y, Tawada A, Matsubara H, Yokosuka O. Fatal Diaphragmatic Hernia following Radiofrequency Ablation for Hepatocellular Carcinoma: A Case Report and Literature Review. Case Rep Oncol. 2015 May 28;8(2):238-45. doi: 10.1159/000431310. PubMed PMID: 26120308; PubMed Central PMCID: PMC4478306.
  29. Tawada A, Kanda T, Yokosuka O. Current and future directions for treating hepatitis B virus infection. World J Hepatol. 2015 Jun 18;7(11):1541-52. doi: 10.4254/wjh.v7.i11.1541. Review. PubMed PMID: 26085913; PubMed Central PMCID: PMC4462692.
  30. Nakamoto S, Kanda T, Shirasawa H, Yokosuka O. Antiviral therapies for chronic hepatitis C virus infection with cirrhosis. World J Hepatol. 2015 May 18;7(8):1133-41. doi: 10.4254/wjh.v7.i8.1133. Review. PubMed PMID: 26052402; PubMed Central PMCID: PMC4450190.
  31. Sasaki R, Kanda T, Nakamoto S, Haga Y, Nakamura M, Yasui S, Jiang X, Wu S, Arai M, Yokosuka O. Natural interferon-beta treatment for patients with chronic hepatitis C in Japan. World J Hepatol. 2015 May 18;7(8):1125-32. doi: 10.4254/wjh.v7.i8.1125. Review. PubMed PMID: 26052401; PubMed Central PMCID: PMC4450189.
  32. Minemura S, Tanaka T, Arai M, Okimoto K, Oyamada A, Saito K, Maruoka D, Matsumura T, Nakagawa T, Katsuno T, Kishimoto T, Yokosuka O. Gene expression profiling of laterally spreading tumors. BMC Gastroenterol. 2015 Jun 6;15:64. doi: 10.1186/s12876-015-0295-1. PubMed PMID: 26048755; PubMed Central PMCID: PMC4456718.
  33. Maruyama H, Kondo T, Kiyono S, Sekimoto T, Takahashi M, Okugawa H, Yokosuka O. Relationship and interaction between serum sodium concentration and portal hemodynamics in patients with cirrhosis. J Gastroenterol Hepatol. 2015 Nov;30(11):1635-42. doi: 10.1111/jgh.13006. PubMed PMID: 25968445.
  34. Kurosawa J, Tawada K, Mikata R, Ishihara T, Tsuyuguchi T, Saito M, Shimofusa R, Yoshitomi H, Ohtsuka M, Miyazaki M, Yokosuka O. Prognostic relevance of apparent diffusion coefficient obtained by diffusion-weighted MRI in pancreatic cancer. J Magn Reson Imaging. 2015 Dec;42(6):1532-7. doi: 10.1002/jmri.24939. PubMed PMID: 25946483.
  35. Omata M, Kanda T, Yokosuka O, Crawford D, Al-Mahtab M, Wei L, Ibrahim A, Lau GK, Sharma BC, Hamid SS, Chuang WL, Dokmeci AK. Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries. Hepatol Int. 2015 Oct;9(4):486-507. doi: 10.1007/s12072-015-9630-4. Review. PubMed PMID: 25941137.
  36. Ogasawara S, Chiba T, Ooka Y, Kanogawa N, Motoyama T, Suzuki E, Tawada A, Azemoto R, Shinozaki M, Yoshikawa M, Yokosuka O. A prognostic score for patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization. PLoS One. 2015 Apr 28;10(4):e0125244. doi: 10.1371/journal.pone.0125244. PubMed PMID: 25919025; PubMed Central PMCID: PMC4412579.
  37. Sakai Y, Tsuyuguchi T, Sugiyama H, Sasaki R, Sakamoto D, Nakamura M, Watanabe Y, Nishikawa T, Yasui S, Mikata R, Yokosuka O. Endoscopic papillary large balloon dilation for bile duct stones in elderly patients. World J Clin Cases. 2015 Apr 16;3(4):353-9. doi: 10.12998/wjcc.v3.i4.353. PubMed PMID: 25879007; PubMed Central PMCID: PMC4391005.
  38. Mizokami M, Yokosuka O, Takehara T, Sakamoto N, Korenaga M, Mochizuki H, Nakane K, Enomoto H, Ikeda F, Yanase M, Toyoda H, Genda T, Umemura T, Yatsuhashi H, Ide T, Toda N, Nirei K, Ueno Y, Nishigaki Y, Betular J, Gao B, Ishizaki A, Omote M, Mo H, Garrison K, Pang PS, Knox SJ, Symonds WT, McHutchison JG, Izumi N, Omata M. Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial. Lancet Infect Dis. 2015 Jun;15(6):645-53. doi: 10.1016/S1473-3099(15)70099-X. PubMed PMID: 25863559.
  39. Ogasawara S, Chiba T, Ooka Y, Kanogawa N, Saito T, Motoyama T, Suzuki E, Tawada A, Kanai F, Yokosuka O. Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors. Invest New Drugs. 2015 Jun;33(3):729-39. doi: 10.1007/s10637-015-0237-3. PubMed PMID: 25861764.
  40. Sekimoto T, Maruyama H, Kiyono S, Kondo T, Shimada T, Takahashi M, Yokosuka O, Yamaguchi T. Liver Stiffness: A Significant Relationship with the Waveform Pattern in the Hepatic Vein. Ultrasound Med Biol. 2015 Jul;41(7):1801-7. doi: 10.1016/j.ultrasmedbio.2015.03.002. PubMed PMID: 25858000.
  41. Hirotsu Y, Kanda T, Matsumura H, Moriyama M, Yokosuka O, Omata M. HCV NS5A resistance-associated variants in a group of real-world Japanese patients chronically infected with HCV genotype 1b. Hepatol Int. 2015 Jul;9(3):424-30. doi: 10.1007/s12072-015-9624-2. PubMed PMID: 25791176.
  42. Sato T, Kondo F, Ebara M, Sugiura N, Okabe S, Sunaga M, Yoshikawa M, Suzuki E, Ogasawara S, Shinozaki Y, Ooka Y, Chiba T, Kanai F, Kishimoto T, Nakatani Y, Fukusato T, Yokosuka O. Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study. Hepatol Int. 2015 Apr;9(2):330-6. doi: 10.1007/s12072-015-9620-6. PubMed PMID: 25788204; PubMed Central PMCID: PMC4387310.
  43. Kamezaki H, Azemoto R, Yokosuka O, Fujimoto T, Obu M, Saito M, Yoshida Y, Koma Y, Maruyama H, Fujimori M. Suspicion of superior mesenteric artery syndrome in a patient with severe gastric dilatation after catheter ablation. Intern Med. 2015;54(6):605-9. doi: 10.2169/internalmedicine.54.3276. PubMed PMID: 25786450.
  44. Kanda T, Yokosuka O, Omata M. Faldaprevir for the treatment of hepatitis C. Int J Mol Sci. 2015 Mar 4;16(3):4985-96. doi: 10.3390/ijms16034985. Review. PubMed PMID: 25749475; PubMed Central PMCID: PMC4394460.
  45. Jiang X, Kanda T, Nakamoto S, Saito K, Nakamura M, Wu S, Haga Y, Sasaki R, Sakamoto N, Shirasawa H, Okamoto H, Yokosuka O. The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells. Biochem Biophys Res Commun. 2015 Mar 20;458(4):908-12. doi: 10.1016/j.bbrc.2015.02.058. PubMed PMID: 25704089.
  46. Kanogawa N, Ogasawara S, Chiba T, Saito T, Motoyama T, Suzuki E, Ooka Y, Tawada A, Kanda T, Mikami S, Azemoto R, Kaiho T, Shinozaki M, Ohtsuka M, Miyazaki M, Yokosuka O. Sustained virologic response achieved after curative treatment of hepatitis C virus-related hepatocellular carcinoma as an independent prognostic factor. J Gastroenterol Hepatol. 2015 Jul;30(7):1197-204. doi: 10.1111/jgh.12925. PubMed PMID: 25682720.
  47. Okusaka T, Ueno H, Ikeda M, Mitsunaga S, Ozaka M, Ishii H, Yokosuka O, Ooka Y, Yoshimoto R, Yanagihara Y, Okita K. Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma. Hepatol Res. 2015 Dec;45(13):1283-91. doi: 10.1111/hepr.12504. PubMed PMID: 25676869.
  48. Maruyama H, Kondo T, Kiyono S, Sekimoto T, Takahashi M, Yokosuka O. Influence of splenorenal shunt on long-term outcomes in cirrhosis. Scand J Gastroenterol. 2015 May;50(5):593-600. doi: 10.3109/00365521.2014.1003401. PubMed PMID: 25635924.
  49. Nishikawa T, Tsuyuguchi T, Ishigami H, Sakai Y, Sugiyama H, Nakatani Y, Ohtsuka M, Miyazaki M, Yokosuka O. Peroral cholangioscopy-guided forceps biopsy to evaluate a cicatricial stricture of the biliary duct (with video). Gastrointest Endosc. 2015 Apr;81(4):1030-1; discussion 1031. doi: 10.1016/j.gie.2014.10.008. PubMed PMID: 25597423.
  50. Matsumoto A, Yatsuhashi H, Nagaoka S, Suzuki Y, Hosaka T, Tsuge M, Chayama K, Kanda T, Yokosuka O, Nishiguchi S, Saito M, Miyase S, Kang JH, Shinkai N, Tanaka Y, Umemura T, Tanaka E. Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B. Hepatol Res. 2015 Dec;45(12):1195-202. doi: 10.1111/hepr.12488. PubMed PMID: 25594111.
  51. Maruoka D, Arai M, Ishigami H, Okimoto K, Saito K, Minemura S, Matsumura T, Nakagawa T, Katsuno T, Yokosuka O. Sporadic nonampullary duodenal adenoma/carcinoma is associated with not only colon adenoma/carcinoma but also gastric cancer: association of location of duodenal lesions with comorbid diseases. Scand J Gastroenterol. 2015 Mar;50(3):333-40. doi: 10.3109/00365521.2014.1003399. PubMed PMID: 25582657.
  52. Fujiwara K, Yasui S, Nakano M, Yonemitsu Y, Arai M, Kanda T, Fukuda Y, Oda S, Yokosuka O. Severe and fulminant hepatitis of indeterminate etiology in a Japanese center. Hepatol Res. 2015 Oct;45(10):E141-9. doi: 10.1111/hepr.12483. PubMed PMID: 25582192.
  53. Nakamura M, Kanda T, Nakamoto S, Haga Y, Sasaki R, Jiang X, Yasui S, Arai M, Yokosuka O. Reappearance of serum hepatitis B viral DNA in patients with hepatitis B surface antigen seroclearance. Hepatology. 2015 Oct;62(4):1329. doi: 10.1002/hep.27693. PubMed PMID: 25573053.
  54. Fujiwara K, Oda S, Abe R, Yokosuka O. On-line hemodiafiltration or high-flow continuous hemodiafiltration is one of the most effective artificial liver support devices for acute liver failure in Japan. J Hepatobiliary Pancreat Sci. 2015 Mar;22(3):246-7. doi: 10.1002/jhbp.204. Review. PubMed PMID: 25565563.
  55. Maruyama H, Kondo T, Sekimoto T, Takahashi M, Fujiwara K, Imazeki F, Yokosuka O. Retrograde detection of the intrahepatic portal vein in primary biliary cirrhosis: is sinusoidal blockage the underlying pathophysiology? Eur J Gastroenterol Hepatol. 2015 Mar;27(3):321-7. doi: 10.1097/MEG.0000000000000268. PubMed PMID: 25563140.
  56. Tawada A, Chiba T, Ooka Y, Kanogawa N, Saito T, Motoyama T, Ogasawara S, Suzuki E, Kanai F, Yoshikawa M, Yokosuka O. Transarterial chemoembolization with miriplatin plus epirubicin in patients with hepatocellular carcinoma. Anticancer Res. 2015 Jan;35(1):549-54. PubMed PMID: 25550601.
  57. Kanda T, Yokosuka O. The androgen receptor as an emerging target in hepatocellular carcinoma. J Hepatocell Carcinoma. 2015 Jun 26;2:91-9. doi: 10.2147/JHC.S48956. Review. PubMed PMID: 27508198; PubMed Central PMCID: PMC4918288.
  58. Sekimoto T, Maruyama H, Kondo T, Shimada T, Kiyono S, Yokosuka O. Potential stagnation in the splanchnic hemodynamics demonstrated by the dynamic microbubbles in chronic liver disease. J Gastroenterol Hepatol. 2015 Jun;30(6):1001-8. doi: 10.1111/jgh.12875. PubMed PMID: 25532613.
  59. Suzuki E, Ooka Y, Chiba T, Kobayashi K, Kanogawa N, Motoyama T, Saito T, Ogasawara S, Tawada A, Yokosuka O. Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma. Clin J Gastroenterol. 2015 Feb;8(1):41-6. doi: 10.1007/s12328-014-0542-y. PubMed PMID: 25481841; PubMed Central PMCID: PMC4331596.
  60. Ohyama H, Mikata R, Ishihara T, Tsuyuguchi T, Sakai Y, Sugiyama H, Yasui S, Ishii K, Itoh S, Nishikawa T, Watanabe Y, Yokosuka O. Efficacy of stone density on noncontrast computed tomography in predicting the outcome of extracorporeal shock wave lithotripsy for patients with pancreatic stones. Pancreas. 2015 Apr;44(3):422-8. doi: 10.1097/MPA.0000000000000277. PubMed PMID: 25438070.
  61. Kawaguchi T, Nagao Y, Abe K, Imazeki F, Honda K, Yamasaki K, Miyanishi K, Taniguchi E, Kakuma T, Kato J, Seike M, Yokosuka O, Ohira H, Sata M. Effects of branched-chain amino acids and zinc-enriched nutrients on prognosticators in HCV-infected patients: a multicenter randomized controlled trial. Mol Med Rep. 2015 Mar;11(3):2159-66. doi: 10.3892/mmr.2014.2943. PubMed PMID: 25394681.
  62. Shimada T, Maruyama H, Kondo T, Sekimoto T, Takahashi M, Yokosuka O. Impact of splenic circulation: non-invasive microbubble-based assessment of portal hemodynamics. Eur Radiol. 2015 Mar;25(3):812-20. doi: 10.1007/s00330-014-3476-3. PubMed PMID: 25361826.
  63. Fujiwara K, Yasui S, Yonemitsu Y, Arai M, Kanda T, Nakano M, Oda S, Yokosuka O. Fixed point observation of etiology of acute liver failure according to the novel Japanese diagnostic criteria. J Hepatobiliary Pancreat Sci. 2015 Mar;22(3):225-9. doi: 10.1002/jhbp.178. PubMed PMID: 25339364.
  64. Fujiwara K, Yasui S, Yonemitsu Y, Arai M, Kanda T, Nakano M, Oda S, Yokosuka O. Importance of the poor prognosis of severe and fulminant hepatitis in the elderly in an era of a highly aging society: Analysis in a Japanese center. Hepatol Res. 2015 Aug;45(8):863-71. doi: 10.1111/hepr.12426. PubMed PMID: 25238570.
  65. Maruoka D, Arai M, Tanaka T, Okimoto K, Oyamada A, Minemura S, Tsuboi M, Matsumura T, Nakagawa T, Kanda T, Katsuno T, Imazeki F, Yokosuka O. Mosapride citrate increases postprandial glucagon-like peptide-1, insulin, and gene expression of sweet taste receptors. Dig Dis Sci. 2015 Feb;60(2):345-53. doi: 10.1007/s10620-014-3271-7. PubMed PMID: 25008428.
  66. Chiba T, Saito T, Yuki K, Zen Y, Koide S, Kanogawa N, Motoyama T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Otsuka M, Miyazaki M, Iwama A, Yokosuka O. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma. Int J Cancer. 2015 Jan 15;136(2):289-98. doi: 10.1002/ijc.28985. PubMed PMID: 24844570.
  67. Yasui S, Fujiwara K, Nakamura M, Miyamura T, Yonemitsu Y, Mikata R, Arai M, Kanda T, Imazeki F, Oda S, Yokosuka O. Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B. J Viral Hepat. 2015 Feb;22(2):94-102. doi: 10.1111/jvh.12258. PubMed PMID: 24750410.